FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4214482009> ?p ?o ?g. }

• W4214482009 abstract "TNF-α inhibitors are widely used in rheumatoid arthritis (RA) with varying success. Response to TNF-α inhibition may reflect the evolution of rheumatoid inflammation through fluctuating stages of TNF-α dependence. Our aim was to assess plasma concentrations of Th-17-related cytokines and the presence of circulating effector T-cells to identify predictors of response to TNF-α inhibitors.Ninety-three people with RA were seen prior to and 4-6 months after commencing etanercept or adalimumab. Plasma concentrations of Th17-related cytokines, circulating effector T-cells, their production of relevant transcription factors and intracellular cytokines were measured at baseline. EULAR response criteria were used to define poor (ΔDAS28 ≤ 1.2 and/or DAS28 > 3.2) and good (ΔDAS28 > 1.2 and DAS28 ≤ 3.2) responders. Multivariate logistic regression was used to identify predictors of response.Participants with plasma IL-23 present at baseline were more likely to be poor responders [15/20 (75%) of IL-23+ versus 36/73 (49.3%) of IL-23-; p = 0.041]. While frequencies of Th1, Th17, ex-Th17 and Treg cell populations were similar between good and poor responders to anti-TNF therapy, IL-17A+IFNγ+ ex-Th17 cells were more prevalent in good responders (0.83% of ex-TH17 cells) compared to poor responders (0.24% of ex-Th17 cells), p = 0.023. Both plasma IL-23 cytokine status (OR = 0.17 (95% CI 0.04-0.73)) and IL-17A+IFNγ+ ex-Th17 cell frequency (OR = 1.64 (95% CI 1.06 to 2.54)) were independently associated with a good response to anti-TNF therapy. Receiver operator characteristic (ROC) analysis, including both parameters, demonstrated an area under the ROC curve (AUC) of 0.70 (95% CI 0.60-0.82; p = 0.001).Plasma IL-23 and circulating IL-17A+IFNγ+ ex-Th17 cells are independently associated with response to anti-TNF therapy. In combination, plasma IL-23 and circulating IL-17A+IFNγ+ ex-Th17 cells provide additive value to the prediction of response to anti-TNF therapy in RA." @default.
• W4214482009 created "2022-03-02" @default.
• W4214482009 creator A5020199989 @default.
• W4214482009 creator A5023287058 @default.
• W4214482009 creator A5058941145 @default.
• W4214482009 creator A5061552694 @default.
• W4214482009 creator A5078805088 @default.
• W4214482009 date "2022-02-26" @default.
• W4214482009 modified "2023-10-05" @default.
• W4214482009 title "Plasma interleukin-23 and circulating IL-17A+IFNγ+ ex-Th17 cells predict opposing outcomes of anti-TNF therapy in rheumatoid arthritis" @default.
• W4214482009 cites W1488100582 @default.
• W4214482009 cites W1523458199 @default.
• W4214482009 cites W1966140981 @default.
• W4214482009 cites W1988157050 @default.
• W4214482009 cites W2001917088 @default.
• W4214482009 cites W2002133510 @default.
• W4214482009 cites W2014291928 @default.
• W4214482009 cites W2029463219 @default.
• W4214482009 cites W2071530841 @default.
• W4214482009 cites W2075670765 @default.
• W4214482009 cites W2090355700 @default.
• W4214482009 cites W2099229060 @default.
• W4214482009 cites W2114768841 @default.
• W4214482009 cites W2120989550 @default.
• W4214482009 cites W2128952811 @default.
• W4214482009 cites W2130420229 @default.
• W4214482009 cites W2135808113 @default.
• W4214482009 cites W2137717947 @default.
• W4214482009 cites W2137809958 @default.
• W4214482009 cites W2151440511 @default.
• W4214482009 cites W2154716537 @default.
• W4214482009 cites W2167331183 @default.
• W4214482009 cites W2169015738 @default.
• W4214482009 cites W2178538398 @default.
• W4214482009 cites W2318956962 @default.
• W4214482009 cites W2599441629 @default.
• W4214482009 cites W2613469721 @default.
• W4214482009 cites W2725127520 @default.
• W4214482009 cites W2725832147 @default.
• W4214482009 cites W2734431490 @default.
• W4214482009 cites W2791371888 @default.
• W4214482009 cites W2791732570 @default.
• W4214482009 cites W2886898556 @default.
• W4214482009 cites W2969847140 @default.
• W4214482009 cites W2972371423 @default.
• W4214482009 cites W2977559163 @default.
• W4214482009 cites W2982256390 @default.
• W4214482009 cites W3034020222 @default.
• W4214482009 cites W3083830923 @default.
• W4214482009 cites W3100146807 @default.
• W4214482009 cites W3134328949 @default.
• W4214482009 doi "https://doi.org/10.1186/s13075-022-02748-3" @default.
• W4214482009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35219333" @default.
• W4214482009 hasPublicationYear "2022" @default.
• W4214482009 type Work @default.
• W4214482009 citedByCount "7" @default.
• W4214482009 countsByYear W42144820092022 @default.
• W4214482009 countsByYear W42144820092023 @default.
• W4214482009 crossrefType "journal-article" @default.
• W4214482009 hasAuthorship W4214482009A5020199989 @default.
• W4214482009 hasAuthorship W4214482009A5023287058 @default.
• W4214482009 hasAuthorship W4214482009A5058941145 @default.
• W4214482009 hasAuthorship W4214482009A5061552694 @default.
• W4214482009 hasAuthorship W4214482009A5078805088 @default.
• W4214482009 hasBestOaLocation W42144820091 @default.
• W4214482009 hasConcept C126322002 @default.
• W4214482009 hasConcept C17991360 @default.
• W4214482009 hasConcept C198451711 @default.
• W4214482009 hasConcept C203014093 @default.
• W4214482009 hasConcept C2777138892 @default.
• W4214482009 hasConcept C2777226972 @default.
• W4214482009 hasConcept C2777575956 @default.
• W4214482009 hasConcept C2778690821 @default.
• W4214482009 hasConcept C2780132546 @default.
• W4214482009 hasConcept C47348012 @default.
• W4214482009 hasConcept C71924100 @default.
• W4214482009 hasConceptScore W4214482009C126322002 @default.
• W4214482009 hasConceptScore W4214482009C17991360 @default.
• W4214482009 hasConceptScore W4214482009C198451711 @default.
• W4214482009 hasConceptScore W4214482009C203014093 @default.
• W4214482009 hasConceptScore W4214482009C2777138892 @default.
• W4214482009 hasConceptScore W4214482009C2777226972 @default.
• W4214482009 hasConceptScore W4214482009C2777575956 @default.
• W4214482009 hasConceptScore W4214482009C2778690821 @default.
• W4214482009 hasConceptScore W4214482009C2780132546 @default.
• W4214482009 hasConceptScore W4214482009C47348012 @default.
• W4214482009 hasConceptScore W4214482009C71924100 @default.
• W4214482009 hasFunder F4320320825 @default.
• W4214482009 hasFunder F4320334749 @default.
• W4214482009 hasIssue "1" @default.
• W4214482009 hasLocation W42144820091 @default.
• W4214482009 hasLocation W42144820092 @default.
• W4214482009 hasLocation W42144820093 @default.
• W4214482009 hasLocation W42144820094 @default.
• W4214482009 hasOpenAccess W4214482009 @default.
• W4214482009 hasPrimaryLocation W42144820091 @default.
• W4214482009 hasRelatedWork W1555548379 @default.
• W4214482009 hasRelatedWork W1973470095 @default.
• W4214482009 hasRelatedWork W1976481621 @default.
• W4214482009 hasRelatedWork W1979251453 @default.

• next